biden's 1.70 $5 trillion economic agenda today, lining up for a vote later on this week. speaker pelosi is pressing ahead despite house moderates echoing joe manchin's complain about not knowing the full cost and economic impact of the tax and spending bill. advisors to the centers for disease control and prevention are meeting today to discuss giving the pfizer biontech coronavirus vaccine to children ages five to 11. they are expected to recommend moving forward. the fda has already authorized the two shot regimen. the biden administration says it has enough vaccines for all 28 million children in this age group. former rope you would makers have scored the pharmaceuticals industries's first win. johnson & johnson, and others

defeated the suit in california. the suit claiming they created a public health crisis through misleading advertising. the government wanted money to beef up the leasing and drug treatment budgets. ethiopia's government is urging residents of its capital to arm themselves and protect their neighborhoods, after rebel fighters in the north of the country captured two key towns on a main route. the government has declared a nationwide state of emergency as a year-long, act in the nation escalates. -- conflict in the nation escalates. global news 24 hours a day, on-air, and on bloomberg quicktake, powered by more than 2700 journalists and analysts in over 120 countries. i'm mark crumpton. this is bloomberg. matt: it is 1:00 in p.m., 5:00

in london 1:00 a.m. in hong , kong. i'm matt miller. welcome to bloomberg markets. here are the top stories we are following on the bloomberg and from around the world. the federal reserve is expected to announce it will kick off tapering this week as concerns over inflation take hold. we will look ahead to wednesdays rate decision with the portfolio manager of fixed income. later in the hour, we will have a conversation with the chairman and ceo of pfizer. and ether hits a record high. we will discuss the moves and the push by lawmakers to regulate crypto and stable coins especially for fear that it could threaten the u.s. economy. let's take a quick check on what is going on in the u.s. markets. s&p 500 up .4%. 4631 right now on the s&p 500.

i saw someone tweet the other day, stocks can never go down. it is starting to feel like that. the u.s. 10-year yield coming down as investors seek the safety of government bonds. definitely look to the bond market for something as we approach the fed meeting. the dollar index up .2%. nymex crude down $.46 a barrel, $83.59. the markets are moving, especially when it comes to rental car markets, retail, and meme stocks moving. shares of avis absolutely soaring today. over 20 million shares have treated hands, so the volume is hitting its highest level. the stock has actually doubled here, your grand lake coming amid a flurry of retail trading activity after avis says it will

play a big role in the increased adoption of electric cars in the u.s. that may sound familiar because hertz just made the announcement that they would buy 100,000 teslas. elon musk tweeted overnight at there has not been a contract signed and retail investors may be speculating that avis could get the jump on their competitor and go in and buy teslas. that is an interesting story to pay attention to, another reason to start looking back at retail platforms like wall street bets on reddit. let's turn to the fed. according to a survey, the fed will start tapering its massive asset buying program this month in the midst of the concern i'm growing inflation taken homework -- taking hold. joining us now is the parametric director of fixed income. thank you for joining us.

let me ask you about the term inflation debate. can we stop using that? do we all agree now that inflation is here and it is not transitory? >> yes, by definition, we can all agree inflation is no longer transitory, unless we are redefining the word to mean over an extended period of time. supply chain issues are the cause of that. not necessarily seeing any easing of that, so there is more concern as we thing -- see things priced in the market. we could be seeing higher inflation and supply chain issues the remainder of the year and into next year as well. i am not sure that this is to your point a debate anymore. it is here to stay for some time. matt: what does the fed do about that, what do we get from jerome powell and company tomorrow? nisha: it is a very tricky

situation just in terms of how they navigate the message, lay that out. there is no surprise the announcement of the tapering, plans around that, relatively slow and modest tapering will start. where the pressure comes in, as other central banks have taken a more hawkish tone, are increasingly pricing in, markets are looking at raising rates, and this inflationary environment continues, the fed will, i think, try to push back a little bit on that narrative and maybe try to buy some time by suggesting this could be a little bit temporary. i don't want to use the word transitory. and that they want to actually i think chairman powell sticks

with the message of let's see how this plays out. there are still some weaker components. we could see improvement in the labor market. what will be interesting is how the market takes the message, if the fed is not doing their job to combat inflation quickly enough. matt: what can they do? if you look at the root causes and you say this is because of a supply chain issue, shipping problems, because of a labor shortage, there is not much you can do with rates to effect that sort of a situation. it is not on the demand side where the fed has the most power. -- affect that sort of a situation. nisha: we will probably see that and hear that from chairman powell. there is nothing the fed can do about this. the other issue is that when you weigh the risk of preemptively

raising rates to combat inflation where it was not caused by anything from excessive fiscal right policy or a loose monetary policy because of supply chain issues, i think the fed will err on the side of caution and not want to make the same mistake of cycling in growth which is what happened post financial crisis. clearly different era, different things took place, but to your point, this is not anything that the fed is convinced they can control and they will want to see how this plays out. matt: when you look at the market pricing, the expectation is for the fed to raise rates -- and i am getting beyond tomorrow and the taper discussion to what happens in 2022 -- more than once. if you talk to our rate strategist, he expects two rate increases in 2022, but that is

because he thinks the recovery will be stable and solid and the economy will be growing in a way where the fed can raise rates in a healthy situation. what is your outlook? nisha: i think there is a good chance of that. i would say that is the great news, seeing this rebound in economic growth, having that optimism into next year is very well-founded. the reality is, if you take a look at individual balance sheets, the ability of consumers to continue to buy goods and services, it looks very healthy. i think that will continue well into next year especially as we are coming out of the pandemic, and if we don't have another variant, surge of cases that takes place. as we hit more about normalcy into next year, if we see easing of those supply chain issues to where demand is not the issue but meeting that demand, we will see plenty of demand from a

consumer spending standpoint. companies are coming into 2022, going into 2022 with fairly healthy balance sheets as well, strong earnings more or less. i think the foundation for a strong economy is certainly there. if supply chain issues ease and we see inflation because of very strong economic growth getting too hot, inflation running too hot for too long, i think that's a possibility. a lot of factors to take into consideration, particularly around any further variants and where cases go. matt: last question in terms of investing, on the bloomberg today, it pointed out at dow 36,000, it's an interesting time to stop and take stock -- no pun intended -- of things like yields.

only getting 1.8% from the blue chips. soon enough, you'll be getting more than that. some people think from fixed income. what is your view on that balance and the possible shift? nisha: given where the yield environment is right now, and we continue to see relatively healthy demand for it, if we see a strong surging yields, there will be more than enough demand in yields to meet any sellout that we could see on the fixed income side. i reality is there is a lot of cash that needs to find a home. with equity valuations where they are, with investors looking for a more balanced approach, even though the stock and bond correlation is falling off as of late, i think you'll have a very strong demand for fixed income, especially if we are heading into what investors think is the end of a rate cycle or economic

cycle, and keep that ballast in their portfolio. our investors are looking for that type of exposure, expecting some rate volatility, wanting to take advantage of it. we find a lot of that value today given how tight credit spreads are in the investment grade space. i think there will be no lack of demand if we see that surgeon yield. matt: appreciate your time today, nisha patel, parametric portfolio manager of the extent come. breaking news on netflix. shares were down and are now moving higher on headlines that the streaming video service will introduce video games on mobile devices. so far, it's only for android. looks like they will limit games to adult profiles. netflix is introducing mobile gaming on android. that turns shares higher.

senator joe manchin's waiver on president biden's bill back better plan -- build back better plan. he is one of two senators needed to secure it passage. in an interview with the treasury secretary, he says the framework satisfies manchin's demands. >> the president's does satisfy senator manchin. i understand he wants to read the legislation based on that framework. when you look at the framework, it includes fully paying for the legislation, using tax increases on the wealthy and corporations, including the international minimum tax. it also includes ways to address some of the pressures built in our economy due to the pandemic. for example, i was in philadelphia last week, have the opportunity to sit down with

parents thinking about reentering the labor force. one of their concerns was what do i do with my children not in school? this plan includes the biggest expansion for kids in over 100 years, where kids who are three and four will have guaranteed universal education. in addition to doing that, it will create jobs by providing incentives to those people who are making decisions on how they can hire new employees to do things like help us address climate change and also investing in training for workers in order to make sure our economy is better positioned to compete in the future. >> i said larry summers was very complimentary about the global minimum tax, also complementary about adding resources to the irs to make sure that people are paying their fair share. he said he could not understand why the tech proposals could not go further, to address things like people making less than $10 million a year.

we are not raising the rates on anyone making less than $10 million a year. not addressing carried interest. what do you say to that? i know president biden has made it a priority to address income inequality in this country. >> the first thing i would say is the build back better program goes a long way to that by raising taxes on the wealthiest in america. the president made a number of proposals, and he has made it clear this represents a compromise that includes a number of the proposals he has advocated for but does not include some of the. our job is to make sure that we get this implemented because we know it will include transformative changes for our economy that will help us create jobs, and at the same time, it's paid for in a way that will need , over time, our debt and deficit will go down. matt: another item in -- >> another item in the news

about cryptocurrency. we have a plan b. it is systemically important and we may regulate that way. what do you not have power to do right now that you need power to do? >> what we are attempting to do is provide those in the industry with a regulatory framework in order to make sure they know where they can innovate going forward. regulators within the president's working group developed this report in order to provide congress with our recommendations in terms of what we think they need to do to provide us with the regulatory tools to fully address the potential risks. at the moment, a number of regulators around the table have various authorities to regulate, including the financial stability oversight council, which will look closely at these issues. it is critical from our standpoint that congress acts. it allows us to have a holistic

approach to this emerging industry. matt: that was the u.s. deputy secretary talking with david westin. the supply chain crisis risks taking the world economy down with it. we will break down the news. the new bloomberg economic gauges that show the extent of the bottlenecks. this is bloomberg. ♪

matt: this is bloomberg markets. i'm matt miller. now to today's big take, where bloomberg economic looks at how the world has failed to find any quick fixes to the supply chain pain and what that means for central bankers trying to counter rising inflation.

bottlenecks are still getting worse in parts of the world thanks to a mix of overloaded transportation networks, shortages of labor, and a surge of demand. new indicators developed by bloomberg economics underscores the extremity of the problem. you can see here the u.s. supply constrained indicator, a composite measure of supply that shows shortages just off of a two decade high. the breakdown with delivery times is apparent in supermarkets with empty shelves, ports where ships are backed up far offshore, and car plants were output is held back by the lack of chips. you can read the story on your terminal. you can also go to bloomberg.com to find the full supply of big tech stories. still ahead, ethereum it's a new record high.

lawmakers voice their need for a crackdown on stable coin. it seems like the more they talk about regulation and the more jamie dimon hate it, the faster it goes up. ftx founder sandbank been freed joins me -- sam bankman-fried joined me to talk about crypto. this is bloomberg. ♪

matt: crypto continues to rise. let's bring in sam bankman-fried, ftx founder and ceo. it seems the more we talk about regulation, the more jamie dimon hates on it, the higher it goes. what is behind the rise? sam: i think some of it is news is good news. more attention on it. also a slow adoption through a number of users. every week a few more people enter the space. matt: you had the news of the futures etf a couple weeks ago.

since it hit the new high, it has not moved too much. should we be bummed out? sam: it was up 10% on that news. that is not nothing. ethereum, it may be up on speculation that there may be an ethereum-based etf. further price movement is probably pending further news. matt: why do people in this community go in also for the meme coins, shiba inus, squid games? don't we have enough to deal with? all of these other things? sam: part of it is they will be these tight cycles where they will get a lot of coverage and people willing here about them -- will hear about them for the first time.

i think some people are probably seeking novelty and variety. matt: we had a great store yesterday that wall street is really getting serious about headhunting people that have experience in crypto, making old-school investment bankers shift their focus. are you having to compete with talent for j.p. morgan and goldman sachs? sam: no, although the fact that you are noticing it israel. all the places we are talking to on wall street want to have people in the crypto ecosystem. we are being asked for people with recommendations. so far, i don't think it is competing with us for talent. matt: how much is the headwind regulatory push? how much are you expecting for your compliance costs going up? sam: it is all in the details.

it could be fairly substantial. we are likely to spend north of a billion dollars this year build outs related to regulation and compliance. going forward, a lot depends on the exact details of what regulation takes shape, especially in the united states. it could be substantially more than that if it comes down on the burdensome side. matt: great to have you with us. sam bankman-fried, ftx founder and ceo. from new york, i'm matt miller. this is bloomberg. ♪

mark: i'm mark crumpton with bloomberg first word news. house democrats are considering a proposal that would suspend

the cap on the federal state and local tax deduction for three years and then limit it in 2025 at a threshold higher than $10,000. that is according to new jersey democratic congressman bill pascrell, who is involved in the negotiations. assault deduction is one of several items still under negotiations to connect president biden's economic agenda. the president has launched an assault on methane at the u.n. climate summit in class count. he says reducing emissions of heat trapping gas is one of the most important step that can be taken to curb global warming. president biden: this isn't just something we have to do to protect our environment in the future. it is an enormous opportunity for all of our nations to create jobs and make meeting climate goal a core part of our economic recovery as well. mark: mr. biden tied almost 100 nations have signed a joint u.s. and european union pledge to

reduce global methane admissions by 30% by the year 2030. it looks like new york city mayor bill de blasio is eyeing a run for governor. the mayor has filed the initial paperwork needed for him to run. if he declares his candidacy, he will join a crowded field including governor kathy hochul, new york city public advocate jermaine williams, and new york attorney general letitia james. in september 2019, he ended his presidential run after failing to gain traction. global news 24 hours a day, on-air, and on bloomberg quicktake, powered by more than 2700 journalists and analysts in over 120 countries. i'm mark crumpton. this is bloomberg. ♪

amanda: i'm amanda lang. welcome to bloomberg markets. matt: i'm matt miller. we welcome our bloomberg and bnn bloomberg audiences. here are the top stories we are following for you from around the world. pfizer has produced 2.6 billion doses of its vaccine to date this year, and is ready to make more, just as the vaccine for kids reaches its last hurdle. we will hear from chairman and ceo albert bourla. as it draws on its hybrid experience to improve reliability. it is one of the oldest players in the hybrid market. we will speak to bob carter of toyota motor north america to discuss the company's approach to this market. and canada's most romantic corporate showdown continues, as edward rogers asks a judge to

ask his allies onto the board of rogers communication. we will go live outside the courtroom to get more on that drama. amanda: we are watching markets moving generally in positive territory. toronto is the weakest of the north american markets today. leading is health in the s&p 500. materials are doing well. also seeing the big groups that make up the fangs, consumer discretionary, communications doing well. that is despite weakness from some tech names. amazon and facebook are lower but seeing overall strength for the group. the 5-year holding. we will see if we get bond market reaction tomorrow. quiet today, but we are watching rogers communication's. the stock has been under pressure given the turmoil the company is facing.

the corporate showdown now moving to a vancouver courtroom. the real question is, edward rogers, the son of the founder of the company, asking a judge to validate his move to put five more directors onto the company's board. the company, which includes some of his family members, says some of those directors are illegitimate. all of this may be decided by a judge. we are outside the courtroom in vancouver. paul, thanks for being with us. what do we understand about what the judge will have to answer here? paul: the judge will have to answer whether edward rogers acted legally when using a consent resolution to replace five directors on the board of directors, first ousting five directors and then moving five new directors into their place.

the judge, shelley fitzpatrick, has promised a decision this coming friday, 2:00 pacific time , 5:00 eastern time, after stockmarkets have closed. matt: why is edward rogers in such a hurry to change the board? he has the power to do it at a later date because he controls the control trust, which controls a majority of the voting shares. it is not like he doesn't have the power to do it legally at a different time. it is just questionable about whether he has the power to do it whenever he wants. paul: he is in a big dispute, as you know, with some of his family members who are also members of the rogers control trust, who say he acted illegally. they say he should have held a public shareholders meeting, provided shareholders with materials explaining his rationale. they say those lapses in

governance are so serious as to make the movie legal. what he wants to do -- move illegal. what he wants to do is make a fairly sweeping change at the offices at rogers communication's. he wants the chief executive officer for the past four years out of the job and wants a new head of cable and new head of wireless at rogers communications, and he wants to do that quickly. amanda: we know that rogers is in the process of trying to acquire shaw in canada. but this sends a shadow over the whole thing. any sense that this could derail the acquisition? paul: i would say that we are likely going to get a lot of clarity from this decision, at least -- we will get a ruling from the supreme court as to who is right in this dispute, and

that will lead to which board of directors is the legitimate board of directors. the decision can be appealed to the british columbia court of appeals, so that may be where we are heading next. we just don't know. as for doubt on the transaction, as you know, there has been significant doubt from the day it was announced. we have never seen shaw communications shares rise to the level of the rogers offering, so there are moving parts here. this as to the doubt of the transaction. matt: we will be following at every step of the way. thank you, paul bagnell, talking about the rogers drama. let's turn to the auto industry. toyota reports more than 20% drop in north american sales last month. we will find out what is going on there. clearly, the supply chain crunch and the availability of computer chips is a problem for all

manufacturers, but there is also an ev story that i'm eager to catch up on with bob carter, executive vice president for sales. great to see you. thanks for joining us. let me ask you about the supply chain issue, the shipping and ship problem we've been talking about for so many weeks. is this the only reason that we see a drop in toyota sales the last month? bob: thank you for the time today. our sales came in at about 147,000 in the u.s. last month. as you pointed out, down about 20% versus a year ago, which was before the time that we really experienced the supply chain restrictions. the downward sales is all attributed to manufacturing. some of the supply chain disruptions we had. consumer demand in the united states still remains at near record levels. amanda: those supply chain

issues could be exacerbated by moves to ev. we are reminded that the components required for electric vehicles are rare, and in some cases, hard to come by. are you worried that there will be additional problems down the road that you should be planning for now? bob: exactly right, amanda. the supply disruptions appeared to be somewhat short term the next six months. we are already seeing into november and december, and things are looking much better. hopefully by q1 of 2022, we will start to normalize our production. globally, there is a shortage of batteries. that is one of the reasons why this month we introduced a 13.6 -- 13.6 billion dollar investment into manufacturing of batteries, and one of those will be located here in the u.s. matt: i'm glad you bring that up because some in congress are

talking about giving incentives to consumers to buy cars only from car makers with unionized shops. it seems the biden administration has twin policy agendas. they want to promote ev as well as union labor. does toyota have a problem with that? bob: there is no other way to put it, this is simply bad policy. about 50% of all vehicles produced in the united states, including our own, are produced by manufacturers who are not represented by the uaw. but those plans at the same time offer competitive wages and benefits, have a culture that our team members within these plants keep voting the unions down. it seems to me very contrary to the goal, which we have agreed to, to achieve a 50% mix of

electrified vehicles by 2030. yet, this tax law as proposed, eliminates over half of the manufacturers. for a consumer that would prefer to buy a toyota or tesla or riveon or lucent, they should have that ability and not be disadvantaged by a $4500 tax advantage which is clearly centered to support general motors, ford, and another international company. matt: thank you for joining us. great to get your time. bob carter, executive vice president for sales of north america for toyota. talking about the ev production crisis and the politics that may interfere with the markets. coming up, we will speak to the pfizer chairman and ceo albert bourla on the back of their earnings as they prepared to vaccinate kids. this is bloomberg. ♪

>> we welcome the bloomberg television and radio audiences around the world. we have a special guest, chairman and ceo of pfizer, albert bourla. i have to congratulate, you beat across earnings and revenues today. give us a sense of how you did it. albert: i think we did it because we served approximately a billion patients. this is why we are so proud. we touched a billion people around the earth. 300 million of them were without covid. this is the fundamental behind

every strong financial performance. david: at this point, all of us know pfizer because of your vaccine against covid-19, but how much of your business is the covid-19 vaccine, in terms of revenue and profits? what is the rest of it? albert: we have a very big part of our quarterly earnings, sales and earnings reported through vaccines. for the whole year, pfizer gave guidance a little more than $81 billion of revenue. 36 of this will be covid. david: you are increasing projections on how sales will do a covid-19. going into next year, you have $29 billion but it represents 1.7 billion doses. you have the capacity to produce

more than that. is there upside their? albert: yes, there is upside there. as we speak, we are negotiating with a lot of governments for these purchases. whenever we give guidance, we give contracts in hand. this 29 billion dollars, 1.7 billion doses will be delivered next year because the contracts have been signed. we are negotiating more. we will make 4 billion doses this year. the point i want to make, and i made it in the earnings call, is that most of the discussions right now are with middle and high income countries. mainly with high income countries. i would urge middle income countries that are not in discussions with us to prepare for 2022. i want the doses to go

everywhere, not just high income countries. the prices are not for profit prices for the low income countries. david: how do you allocate? no doubt you are over subscribed. do you take into account the incidents of covid in the country per capita? albert: we are looking at how many doses we have and who wants them. overall, we have invested tremendously in our brilliant scientists and engineers. they will be doing 3 billion doses this year, 4 billion next year. quantity will not be a problem but people need to place orders. all the orders right now are being placed by high and middle income countries. we will have the problem next year that everything will be

going to those countries, not low income. if they place the orders now, we will honor them. david: is the market fairly appraising where pfizer is, given your very strong position with respect to covid-19? i will talk about child vaccines in a moment, but you seem to have a comparative advantage. do you think the market is giving you the full credit? albert: no, i don't. maybe they will see, but i think it is undervalued. the markets are efficient. pretty soon they will see. there are question marks, we are getting the benefit of the doubt, but we are bringing more and more products in our pipeline. with more news, i think this gap will be filled. david: we are talking with albert bourla, the chairman and

ceo of pfizer. you just mentioned new products online. what sort of products are you looking at right now? albert: we are very active in six therapeutic areas. all of them are very productive right now. let me start with antivirals. i know there is high interest. we are working on antivirals right now, studying them in injectables and oral. we expect to bring out that at the end of the year and next year. on the vaccine front, it is not just covid that we are working on. we are working on a plethora of other vaccines. rsv is a major disease that affects a lot of humankind. we are recruiting rapidly in our

finals. we hope that i next year we hope to have -- find a year we hope to have results -- by next year we hope to have results. that is just to mention a few of the vaccines that we are working on right now. in terms of oncology, we are working on next generation treatments for breast and prostate cancer we are working right now in lymphoma. we are very optimistic. we are optimistic that we can have a medicine that will make a difference. we are working on rare diseases. we have had a very big program of gene therapy against

hemophilia, muscle dystrophy. in total, we have 12 programs. i could go on and on. david: that is a pretty impressive list. let me come back to a timely topic today. it is thought that the cdc may, as early as today, approve the covid-19 vaccine for children five to 11. when do you anticipate, if the cdc moves as expected, that we will have shots in arms? albert: i think immediately. we already worked with the u.s. government over the weekend, had discussions about logistics, operations. started sending doses in dozens of states. i think we will have enough doses to start immediately. david: you have a major contract for u.s. domestic covid-19

vaccines. will that include children's vaccines, and how will you price them? albert: we have included 115 million children's doses right now, that the u.s. government has committed or orders. this is enough quantity for all children in the u.s.. the u.s. government is not only counting on us to cover the population. the prices are the same for the adult dose. david: what about overseas, exporting possible vaccines for children? do you anticipate that, and if so, on what terms? albert: yes, we are also producing. we will be able to present to other countries the manufacturing size we have in europe. people have enough for all. david: let me talk about the mrna platform that you develop with biontech. discuss the further implications

of that, and will that always be with biontech? do you continue to address new problems with mrna? albert: we are having the first horizons in the mrna technology, developing vaccine for more infectious diseases. we already have covid, working on flu mrna, multiple other targets of infectious disease that have not been disclosed yet. we will when the time comes, but we are working on them. the second way would be in oncology, using the mrna to be able to attack your tumors, give instruction to your body to attack the tumors. and the third way is for rare diseases, using mrna technology to correct the mistakes in your

dna from these diseases. breakthrough technologies, we will provide more information as our investments and studies mature. david: are you working with biontech? albert: we are extremely satisfied with the work that we are doing with biontech. we are discussing further operations on multiple fronts. i don't have anything to announce right now, but biontech has been a very trusted partner of pfizer, and i believe they feel the same for us. david: you mention antivirals, what about a covid pill? we have one from merck. when do we expect one from pfizer? albert: congratulations to them. there is no other oral pill, and i wish them well on their discussion with regulators in the approval. we are working also on an oral pill, injectable. we have three studies right now.

the first study is similar to the one that merck revealed results. people that have comorbidities and other diseases. we have another one -- david: so sorry, but we have to leave it there. pfizer chairman and ceo, albert bourla. amanda: our thanks to david westin for that interview with albert bourla. pfizer stock on the move today. we are keeping our eyes on that. for matt miller, i'm amanda lang. this is bloomberg. ♪

>> advisors to the centers for disease control and prevention

are meeting today to discuss giving the pfizer biontech coronavirus vaccine to children ages five to 11 years old. they are expected to recommend moving forward. the food and drug administration has already authorized the two shot regimen. the biden administration says it has enough of the pfizer biontech vaccine for all 28 million children in this age group. today's election for governor of virginia offered the clearest picture yet of how much momentum republicans will have in the 2022 vote for congress. gop candidate -- one gop candidate is backed by donald trump. the second candidate is betting the president's legacy will turn out echo credit voters -- turnout democratic voters. the belgian prime minister said europe was leading the way on climate initiativ